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Background: New generation DES (n-DES) have proved to be more effective than old-generation DES (o-DES) in reducing stent thrombosis, 
myocardial infarction and TVR, but the effect on mortality is still controversial.
methods: Aim of this observational, multicenter study was to compare clinical outcomes in patients (pts) treated with nDES versus oDES in a real-
world large population from Emilia Romagna, Italy (REAL project) between January 2007 and June 2011. Primary objective was the incidence of long-
term MACE (total death, non fatal MI and TVR). Missing imputation of categorical and continuous variables and sensitivity analysis were performed, 
as long as Propensity Score adjustment and Inverse-Probability-Weighting (IPW).
results: Data are available for 5922 pts (2868 nDES and 3054 oDES), with a median FU time of 3 years. After IPW no significant clinical nor 
procedural difference was evident between the two groups.
Results are shown in table 1.
conclusion: In a contemporary large PCI registry, after optimal adjustment for differences, the use of nDES was associated with a significant 31% 
lower risk of myocardial infarction, 18% lower risk of TVR and 57 % lower risk of angiographic stent thrombosis in comparison with o-DES, with no 
difference in the risk of all-cause mortality and MACE, at long term FU.
Table 1. Outcomes in 4283 pts with all complete variables, (2100 nDES, 2183 oDES) 
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death 0.86 0.25 0.67 1.11 0.95 0.70 0.72 1.24 0.92 0.52 0.71 1.18
MI 0.66 0.006 0.50 0.89 0.69 0.02 0.50 0.94 0.69 0.009 0.52 0.91
TVR 0.76 0.004 0.63 0.92 0.83 0.09 0.68 1.03 0.82 0.03 0.68 0.98
MACE 0.81 0.005 0.70 0.94 0.89 0.15 0.76 1.04 0.87 0.06 0.75 1.00
Stent
thrombosis
0.48 0.082 0.21 1.09 0.53 0.16 0.21 1.29 0.43 0.04 0.19 0.99
* CRUDE: Cox model
° ADJUSTED: Cox model with Propensity Score as covariate
# WEIGHTED: IPW Cox model
